Hanoi requires not to trade, distribute, or use fake Cefuroxim 500mg medicine.

Hanoi Department of Health received Official Dispatch No. 2824/QLD-CL from the Department of Drug Administration regarding counterfeit Cefuroxim 500mg, specifically the counterfeit drug label says Cefuroxim 500mg film-coated tablets.

Medicine registration number: VD-31978-19; Batch number: 780124; Manufacturing date: 130124; Expiry date: 130127; Manufacturer: Branch of Central Pharmaceutical Joint Stock Company Vidipha Binh Duong .

Illustration

To ensure safety for users, the Hanoi Department of Health requires medical facilities, drug wholesalers and retailers in the area not to trade, distribute or use fake Cefuroxim 500mg with identifying signs according to Official Dispatch No. 2824/QLD-CL;

Comply with the business and purchase of drugs with clear origin; review the operation of the facility, if detecting drugs with information as stated, promptly notify the Department of Health (Department Inspectorate) for handling measures.

District, town and city health departments notify medical establishments in their management areas not to trade, distribute or use the above-mentioned counterfeit drugs; receive information from establishments, coordinate with relevant departments to conduct inspections of drug trading establishments in the area, verify information and trace the origin of the above-mentioned counterfeit drugs, and handle violations according to their authority (if any).

Hanoi Center for Drug, Cosmetic and Food Testing reviews during the sampling process; strengthens quality control of drugs circulating in the area for drugs at risk of being counterfeited or of poor quality, and reports to the Department of Health (if any) for handling measures.

Also regarding handling violations in the pharmaceutical sector, the Hanoi Department of Health has just announced the recall of Cefaclor 375mg film-coated tablets (Cefaclor); GĐKLH number: VD-14047-11; Batch number: 0124, NSX: 01/23/24; EXP: 01/23/27 produced by the Branch of Pharmaceutical and Medical Biological Joint Stock Company.

This drug is indicated for the treatment of respiratory tract infections caused by sensitive bacteria such as: acute otitis media, acute sinusitis, pharyngitis, recurrent tonsillitis, pneumonia, chronic bronchitis during an episode, uncomplicated lower urinary tract infections (cystitis), skin and soft tissue infections...

The above drug sample does not meet the quality standards for solubility, the average solubility is below 50% compared to the quality standards. This is a level 2 violation drug.

The Hanoi Department of Health requests public health facilities under the sector, non-public health facilities, drug trading enterprises, and drug retail establishments in the area to review and thoroughly recall the drug Cefaclor 375mg film-coated long tablets (Cefaclor); GĐKLH number: VD-14047-11; Batch number: 0124, NSX: 23/01/24; HD: 23/01/27 produced by the Branch of the Pharmaceutical and Medical Biological Joint Stock Company; send recall reports and recall records to the Department of Health and the Department of Drug Administration according to regulations. The Department of Health will inspect and supervise the recall of units and establishments.

The Health Department of districts, towns and cities shall notify the medical establishments under their management; conduct inspections and supervise the implementation of the recall by the establishments (if any).

Source: https://baodautu.vn/ha-noi-yeu-cau-khong-kinh-doanh-phan-phoi-su-dung-thuoc-cefuroxim-500mg-gia-d223017.html